Our findings are partially consistent with a recent study by Fiondella et al., which demonstrated that nigral TDP‐43 pathology played a significant role in movement disorders among patients with FTLD‐TDP (FTLD with TDP‐43 pathology).55 The gene discussed is TARDBP; the disease is movement disorder.